Abstract: According to “2015 State of Innovation” released by Thomson Reuters, China Pharmaceutical University ranked the first in the field of heterocyclic compounds in 2010-2014 among innovation agencies in Asia. In order to fully understand the situation of the new drug research of this university, this paper analyzes its patent application from 2010 to 2014 in the field of heterocyclic compounds. The key applications were summarized. In summary, this university showed its advantage of high filings and high licensing rate in the field of heterocyclic compounds, yet with the shortcomings of low patent applications in PCT. Furthermore, suggestions have been made for the intellectual property management of this university.